 |
|
Risk Factor and Mortality in Patients with Pulmonary Embolism Combined with Infectious Disease
Gi Dong Lee, Sunmi Ju, Ju-Young Kim, Tae Hoon Kim, Jung-Wan Yoo, Seung Jun Lee, Yu Ji Cho, Yi Yeong Jeong, Kyung Nyeo Jeon, Jong Deog Lee, Ho Cheol Kim
Tuberc Respir Dis. 2020;83(2):157-166. Published online 2020 Mar 10 DOI: https://doi.org/10.4046/trd.2019.0037
|
|
Citations to this article as recorded by
 Prevalence and clinical implications of atrial fibrillation in patients hospitalized due to COVID-19: Data from a registry in Poland
Michał Terlecki, Wiktoria Wojciechowska, Marek Klocek, Tomasz Drożdż, Maryla Kocowska-Trytko, Paweł Lis, Christopher Pavlinec, Jan W. Pęksa, Michał Kania, Zbigniew Siudak, Andrzej Januszewicz, Reinhold Kreutz, Maciej Małecki, Tomasz Grodzicki, Marek Rajze
Frontiers in Cardiovascular Medicine.2023;[Epub] CrossRef Unraveling the Molecular Mechanisms of Activated Protein C (APC) in Mitigating Reperfusion Injury and Cardiac Ischemia: a Promising Avenue for Novel Therapeutic Interventions
Nishant Johri, Prithpal S. Matreja, Shalabh Agarwal, Priya Nagar, Deepanshu Kumar, Aditya Maurya
Journal of Cardiovascular Translational Research.2023;[Epub] CrossRef Prophylaxis of Venous Thromboembolism in Patients with Infectious Disease
Hun-Gyu Hwang, Yang-Ki Kim, Myung-Shin Kim, Gune-Il Lim, Sam Schulman
Tuberculosis and Respiratory Diseases.2020; 83(3): 255. CrossRef
|